All News

The initiative to make the public aware of the importance of medication adherence has reached 12 million patients through the support of 120 partner groups.

Comments, posts, and e-mails on subjects ranging from nontraditional PharmD options to insurers and PBMs, healthy lifestyles, and more.

The results of the 9-year IMPROVE-IT trial are in, and the combo performed better than statin mono therapy in key measures.

Jessica Skelley, PharmD, BCACP, Samford University, discusses the pitfalls pharmacies should avoid while using social media.

FDA recently raised concerns that two generic versions of Concerta (methylphenidate hydrochloride extended-release tablets; Janssen Pharmaceuticals) may not be therapeutically equivalent to the brand-name drug.

A Senate panel is scheduled to hold a hearing on November 20, 2014, to investigate why the prices of some generic drugs are skyrocketing.

In the November 4 Drug Topics’ Special Report (15 hospitals to be evaluated on insulin-pen safety), the headline and summary seemed to imply that the 15 hospitals had been singled out due to their unsafe practices with insulin pens. This is not the case. The hospitals were selected to participate in the ASHP’s Mentored Quality Improvement Impact Program for Insulin Pen Safety. Drug Topics regrets any misunderstanding.

Cigna Health and Life Insurance Co. has agreed to provide some lower-cost drugs for HIV/AIDS patients in Florida who sign up for health insurance coverage for 2015.

When stereotypes and reality converge, we may discover that what we see depends on where we stand.

As healthcare educators, pharmacists can help patients learn to use the new health-maintenance technologies.

Insurance carriers just do not cover compounded medications - any compound - for any reason. Why? Because they do not want to.

Here's one way collaborative practice agreements between pharmacists and doctors can make a difference to individuals and communities.

Kelly Howard and Drug Topics readers share 10 more tips on how best to conduct - and survive - the practice of pharmacy.

Dalbavancin treats acute bacterial skin and skin structure infections caused by susceptible strains of Gram-positive organisms.

New Rx, generics, and OTC products

E-mails, posts, and letters from Drug Topics readers.

Is your pharmacy selling homeopathic products? If it is, think again.

A summary of drug-drug interactions and adverse drug reactions connected with metronidazole, a drug widely used in medical and dental practices to counter anaerobic bacteria, amoebae, and parasitic infections.

Patients are going to ask. Pharmacists need to have the answer ready.

Nothing speaks like the voice of experience. Pharmacists everywhere, listen up.

Diabetes has emerged as one of the most common chronic diseases of childhood and adolescence. In order to guide these young people, healthcare providers need to engage them on their own terms, using their own media.

Goose Rawlings has the answer. And it's not what you think.

SGLT2 inhibitors, GLP-1 receptor agonists, inhaled insulin, extended-release treatments, and fixed-dose combination therapies are among the approaches that have emerged to treat the exploding numbers of type 2 diabetes patients.

Historically, unfractionated heparin (UFH) with a vitamin K antagonist has been the standard treatment for deep venous thrombosis (DVT) or pulmonary embolism. More recently, low-molecular-weight heparin (LMWH) combined with vitamin K antagonists has become the most common choice, but newer target-specific oral anticoagulants have widened the range of treatment options.

Almost three-quarters of survey respondents reported that synching their meds improved their medication adherence.

Around the country, a handful of programs enable working pharmacists to obtain nontraditional PharmDs. Here's what you need to know.

When it comes to educating patients and earning recognition from prescribers, pharmacists find that the CDE credential is a win-win.

Pharmacy technicians who want to recertify need to familiarize themselves with the new requirements being phased in over the next few years.